HUMACYTE INC shareholders Q3 2023

HUMACYTE INC's ticker is and the CUSIP is 44486Q103. A total of 84 filers reported holding HUMACYTE INC in Q3 2023. The put-call ratio across all filers is 63.87 and the average weighting 0.0%.

HUMACYTE INC shareholders Q3 2023
NameSharesValueWeighting ↓
Lion Point Capital, LP 235,000$688,5500.31%
Endowment Wealth Management, Inc. 97,518$285,7280.26%
Imprint Wealth LLC 47,072$137,9210.12%
Prescott General Partners LLC 568,246$1,664,9610.11%
GSA CAPITAL PARTNERS LLP 355,918$1,0430.09%
United Asset Strategies, Inc. 143,808$421,3570.05%
HAMILTON LANE ADVISORS LLC 21,893$64,1460.04%
Shay Capital LLC 65,110$190,7720.03%
CLOUGH CAPITAL PARTNERS L P 79,309$232,3750.02%
Powell Investment Advisors, LLC 12,000$35,1600.02%
Kovack Advisors, Inc. 42,000$123,0600.02%
Bay Colony Advisory Group, Inc d/b/a Bay Colony Advisors 17,950$52,5940.01%
Byrne Asset Management LLC 2,000$6,0000.01%
Rokos Capital Management LLP 200,000$587,0000.00%
Bayesian Capital Management, LP 12,641$37,0380.00%
AlphaStar Capital Management, LLC 10,767$31,5470.00%
PHILADELPHIA TRUST CO 10,000$290.00%
China Universal Asset Management Co., Ltd. 2,661$80.00%
Private Advisor Group, LLC 94,980$278,2910.00%
Mendota Financial Group, LLC 500$1,4650.00%

This page lists HUMACYTE INC's shareholders in Q3 2023. To view HUMACYTE INC's shareholder history, click here.